| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-112 |
Sentence |
denotes |
Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine. |
| T2 |
113-247 |
Sentence |
denotes |
Chloroquine (CQ) and hydroxychloroquine (HCQ) are derivatives of 4-aminoquinoline compounds with over 60 years of safe clinical usage. |
| T3 |
248-366 |
Sentence |
denotes |
CQ and HCQ are able to inhibit the production of cytokines such as interleukin- (IL-) 1, IL-2, IL-6, IL-17, and IL-22. |
| T4 |
367-483 |
Sentence |
denotes |
Also, CQ and HCQ inhibit the production of interferon- (IFN-) α and IFN-γ and/or tumor necrotizing factor- (TNF-) α. |
| T5 |
484-659 |
Sentence |
denotes |
Furthermore, CQ blocks the production of prostaglandins (PGs) in the intact cell by inhibiting substrate accessibility of arachidonic acid necessary for the production of PGs. |
| T6 |
660-828 |
Sentence |
denotes |
Moreover, CQ affects the stability between T-helper cell (Th) 1 and Th2 cytokine secretion by augmenting IL-10 production in peripheral blood mononuclear cells (PBMCs). |
| T7 |
829-1010 |
Sentence |
denotes |
Additionally, CQ is capable of blocking lipopolysaccharide- (LPS-) triggered stimulation of extracellular signal-modulated extracellular signal-regulated kinases 1/2 in human PBMCs. |
| T8 |
1011-1161 |
Sentence |
denotes |
HCQ at clinical levels effectively blocks CpG-triggered class-switched memory B-cells from differentiating into plasmablasts as well as producing IgG. |
| T9 |
1162-1229 |
Sentence |
denotes |
Also, HCQ inhibits cytokine generation from all the B-cell subsets. |
| T10 |
1230-1289 |
Sentence |
denotes |
IgM memory B-cells exhibits the utmost cytokine production. |
| T11 |
1290-1358 |
Sentence |
denotes |
Nevertheless, CQ triggers the production of reactive oxygen species. |
| T12 |
1359-1446 |
Sentence |
denotes |
A rare, but serious, side effect of CQ or HCQ in nondiabetic patients is hypoglycaemia. |
| T13 |
1447-1594 |
Sentence |
denotes |
Thus, in critically ill patients, CQ and HCQ are most likely to deplete all the energy stores of the body leaving the patient very weak and sicker. |
| T14 |
1595-1748 |
Sentence |
denotes |
We advocate that, during clinical usage of CQ and HCQ in critically ill patients, it is very essential to strengthen the CQ or HCQ with glucose infusion. |
| T15 |
1749-1821 |
Sentence |
denotes |
CQ and HCQ are thus potential inhibitors of the COVID-19 cytokine storm. |
| T1 |
0-112 |
Sentence |
denotes |
Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine. |
| T2 |
113-247 |
Sentence |
denotes |
Chloroquine (CQ) and hydroxychloroquine (HCQ) are derivatives of 4-aminoquinoline compounds with over 60 years of safe clinical usage. |
| T3 |
248-366 |
Sentence |
denotes |
CQ and HCQ are able to inhibit the production of cytokines such as interleukin- (IL-) 1, IL-2, IL-6, IL-17, and IL-22. |
| T4 |
367-483 |
Sentence |
denotes |
Also, CQ and HCQ inhibit the production of interferon- (IFN-) α and IFN-γ and/or tumor necrotizing factor- (TNF-) α. |
| T5 |
484-659 |
Sentence |
denotes |
Furthermore, CQ blocks the production of prostaglandins (PGs) in the intact cell by inhibiting substrate accessibility of arachidonic acid necessary for the production of PGs. |
| T6 |
660-828 |
Sentence |
denotes |
Moreover, CQ affects the stability between T-helper cell (Th) 1 and Th2 cytokine secretion by augmenting IL-10 production in peripheral blood mononuclear cells (PBMCs). |
| T7 |
829-1010 |
Sentence |
denotes |
Additionally, CQ is capable of blocking lipopolysaccharide- (LPS-) triggered stimulation of extracellular signal-modulated extracellular signal-regulated kinases 1/2 in human PBMCs. |
| T8 |
1011-1161 |
Sentence |
denotes |
HCQ at clinical levels effectively blocks CpG-triggered class-switched memory B-cells from differentiating into plasmablasts as well as producing IgG. |
| T9 |
1162-1229 |
Sentence |
denotes |
Also, HCQ inhibits cytokine generation from all the B-cell subsets. |
| T10 |
1230-1289 |
Sentence |
denotes |
IgM memory B-cells exhibits the utmost cytokine production. |
| T11 |
1290-1358 |
Sentence |
denotes |
Nevertheless, CQ triggers the production of reactive oxygen species. |
| T12 |
1359-1446 |
Sentence |
denotes |
A rare, but serious, side effect of CQ or HCQ in nondiabetic patients is hypoglycaemia. |
| T13 |
1447-1594 |
Sentence |
denotes |
Thus, in critically ill patients, CQ and HCQ are most likely to deplete all the energy stores of the body leaving the patient very weak and sicker. |
| T14 |
1595-1748 |
Sentence |
denotes |
We advocate that, during clinical usage of CQ and HCQ in critically ill patients, it is very essential to strengthen the CQ or HCQ with glucose infusion. |
| T15 |
1749-1821 |
Sentence |
denotes |
CQ and HCQ are thus potential inhibitors of the COVID-19 cytokine storm. |